Sunshine Biopharma Enters Into a Collaboration Agreement with a Leading Lipid Nanoparticle Formulation Company for Its K1.1 Anticancer mRNA Project
16 nov. 2022 08h00 HE
|
Sunshine Biopharma Inc.
MONTREAL, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: “SBFM”), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas,...
The Worldwide Antiviral Drugs Industry is Expected to Reach $50 Billion by 2030
01 nov. 2022 06h28 HE
|
Research and Markets
Dublin, Nov. 01, 2022 (GLOBE NEWSWIRE) -- The "Antiviral Drugs Market, By Drug Type, By Application, By Mechanism of Action, By Distribution Channel, and By Region Forecast to 2030" report has been...
Sunshine Biopharma Announces the Acquisition of Nora Pharma, Adding $10.7 Million in Revenue
20 oct. 2022 08h00 HE
|
Sunshine Biopharma Inc.
MONTREAL, Oct. 20, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: “SBFM”), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral...
Cocrystal Pharma to Present at the LD Micro Main Event XV
19 oct. 2022 08h00 HE
|
Cocrystal Pharma, Inc.
BOTHELL, Wash., Oct. 19, 2022 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that President and co-interim CEO Sam Lee, PhD will present a company overview of their antiviral...
Sunshine Biopharma Increases Support for Anti-Coronavirus Collaborative Research With the University of Arizona
28 juil. 2022 08h10 HE
|
Sunshine Biopharma Inc.
MONTREAL, July 28, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: “SBFM” and SBFMW) (the “Company” or “Sunshine Biopharma”), a pharmaceutical company focused on the research, development...
Sunshine Biopharma Expands Anti-Coronavirus Drug Development Program By Signing A Collaboration Agreement With The University Of Arizona
25 févr. 2022 08h00 HE
|
Sunshine Biopharma Inc.
MONTREAL, Feb. 25, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: “SBFM” and SBFMW) (the “Company” or “Sunshine Biopharma”), a pharmaceutical company focused on the research, development...
Cocrystal Pharma Selects Two Lead Antiviral Drug Candidates for its COVID-19 Oral Drug Program
27 janv. 2022 08h00 HE
|
Cocrystal Pharma, Inc.
Novel broad-spectrum oral lead candidates CDI-988 and CDI-873, discovered using Cocrystal’s antiviral drug discovery platform, demonstrate superior in vitro potency against SARS-CoV-2 and activity...
Antiviral Drugs Market Worth USD 44.2 Billion at 3.2% CAGR by 2026; Rising Prevalence of HIV to Fuel Growth: Fortune Business Insights™
11 nov. 2020 05h37 HE
|
Fortune Business Insights
Pune, India, Nov. 11, 2020 (GLOBE NEWSWIRE) -- The global antiviral drugs market size is set to gain impetus from the improvements in research collaborations of industry giants to develop...